Stem Cell Research & Therapy operates using a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Manuscripts submitted to Stem Cell Research & Therapy will be evaluated initially by the Editors-in-Chief, and then assigned to an Associate Editor who is responsible for designating at least 2 reviewers in order to assess the scientific quality of the submitted material. The reviewers' comments will be considered by the Associate Editor and Editors-in-Chief and a final decision on publication will be made. They consider the quality of the manuscript from a scientific standpoint and its importance and significance in view of the scope of Stem Cell Research & Therapy.